ANTIOS THERAPEUTICS INC.

Profile

Company Names

ANTIOS THERAPEUTICS INC.

Addresses

20 HORSESHOE BEND ROAD, MENDHAM, NJ 07945

575 PHARR ROAD NE, #12260, ATLANTA, GA 30355

575 PHARR ROAD NE, UNIT 12260, ATLANTA, GA 30355

Phone Numbers

215-696-9659
2126983616
4048853000

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$126,399,991.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2021-11-02 
$74,999,993.00 
$85,999,993.00 
$11,000,000.00 
Equity 
3
2021-04-09 
$32,000,000.00 
$100,000,000.00 
$68,000,000.00 
Equity 
2
2020-07-31 
$4,399,999.00 
$5,000,000.00 
$600,001.00 
Equity 
1
2018-11-20 
$14,999,999.00 
$25,000,000.00 
$10,000,001.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
TAMRA 
 
ADAMS 
EXECUTIVE OFFICER
ANTIOS THERAPEUTICS INC.
DAVID 
 
CANNER 
DIRECTOR
ANTIOS THERAPEUTICS INC.   |  TWINSTRAND BIOSCIENCES, INC.
HENRY 
LIN 
CHEN 
DIRECTOR
DELOS CAPITAL FUND, LP   |  ANTIOS THERAPEUTICS INC.   |  DELOS CAPITAL FUND III, LP
ABEL 
 
DE LA ROSA 
EXECUTIVE OFFICER, DIRECTOR
VIVEBIO, LLC   |  ANTIOS THERAPEUTICS INC.   |  XENAGOS BIO, INC.
CRAIG 
 
GORDON 
DIRECTOR
OTR GLOBAL HOLDINGS II, INC.   |  KOLLECTIVE TECHNOLOGY, INC.   |  ANTIOS THERAPEUTICS INC.   |  SALIOGEN THERAPEUTICS, INC.   |  GENNAO BIO, INC.   |  AMLOGENYX INC.   |  RAPALOGIX HEALTH, INC.
PATRICK 
 
HIGGINS 
DIRECTOR
ONCORE BIOPHARMA, INC.   |  ANTIOS THERAPEUTICS INC.   |  XENAGOS BIO, INC.
IDEAN 
 
MARVASTY 
EXECUTIVE OFFICER
ANTIOS THERAPEUTICS INC.   |  MICRON BIOMEDICAL, INC.
DOUGLAS 
 
MAYERS 
EXECUTIVE OFFICER
IDENIX PHARMACEUTICALS INC   |  ANTIOS THERAPEUTICS INC.
GREGORY 
 
MAYES 
EXECUTIVE OFFICER, DIRECTOR
UNIGENE LABORATORIES INC   |  ENGAGE THERAPEUTICS, INC.   |  ANTIOS THERAPEUTICS INC.   |  RECEPTOR HOLDINGS, INC.   |  REUNION NEUROSCIENCE MANAGEMENT, INC.   |  REUNION NEUROSCIENCE, INC.
SCOTT 
 
MORENSTEIN 
DIRECTOR
GEMIN X PHARMACEUTICALS INC   |  VALENCE ADVANTAGE LIFE SCIENCES FUND II, L.P.   |  CELATOR PHARMACEUTICALS INC   |  VELICEPT THERAPEUTICS, INC.   |  MOLECULAR TEMPLATES, INC.   |  ANTIOS THERAPEUTICS INC.   |  PRIMMUNE THERAPEUTICS, INC.   |  PALVELLA THERAPEUTICS, INC.
IYONA 
 
RAJKOMAR 
DIRECTOR
STARGAZER PHARMACEUTICALS, INC.   |  ABCURO, INC.   |  ANTIOS THERAPEUTICS INC.
BENJAMIN 
 
ROVINSKI 
DIRECTOR
AURINIA PHARMACEUTICALS INC.   |  VASCULAR PHARMACEUTICALS, INC.   |  ANTIVA BIOSCIENCES, INC.   |  ANTIOS THERAPEUTICS INC.
NICOLE 
 
VITULIO 
DIRECTOR
ANTIOS THERAPEUTICS INC.
NICOLE 
 
VITULLO 
DIRECTOR
MARINUS PHARMACEUTICALS INC   |  DP VIII ASSOCIATES, L.P.   |  DOMAIN PARTNERS VIII, L.P.   |  VENTIRX PHARMACEUTICALS INC   |  ESPERION THERAPEUTICS, INC.   |  CELATOR PHARMACEUTICALS INC   |  ABREXA PHARMACEUTICALS, INC.   |  VENTIRX PHARMACEUTICALS INC.   |  DOMAIN PARTNERS IX, L.P.   |  CELTAXSYS, INC.   |  COTERA, INC.   |  EXALYS THERAPEUTICS, INC.   |  ANTIOS THERAPEUTICS INC.   |  MARINUS PHARMACEUTICALS, INC.   |  ALLAY THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-11-16
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-11-02 
2021-04-19
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-09 
2020-08-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-07-31 
2018-12-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#